Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 21.09.2026 1 Acta Neuropathol 2 Am J Clin Oncol 1 Childs Nerv Syst 1 Eur J Cancer 10 J Neurooncol 2 J Neuropathol Exp Neurol 3 Neuro Oncol 3 Neuroradiology 2 Neurosurgery 1 Oncogene 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. BRANDENBURG C, Starzetz T, Woltering N, Kumar A, et al
   Complementary use of the DNA methylation-based tumor classification by the Bethesda v3 classifier in routine diagnostics: evaluation in a series of 516 cases.
   Acta Neuropathol. 2026;152:36.
   PubMed         Abstract available
   
   

   
   Am J Clin Oncol

2. ORR D, Becker E, Ding K, McClelland S 3rd, et al
   Impact of COVID on National Practice Patterns of Adjuvant Radiation Therapy Completion in Treatment of Glioblastoma.
   Am J Clin Oncol. 2026 Sep 14. doi: 10.1097/COC.0000000000001359.
   PubMed         Abstract available
   
   
3. PATEL A, Lee V, Nassar AH, Kim SY, et al
   EGFR Mutation Subtype and Risk of Brain Metastases From Non-Small Cell Lung Cancer in the Osimertinib Era: EGFR Subtype and Brain Metastases in NSCLC.
   Am J Clin Oncol. 2026 Sep 15. doi: 10.1097/COC.0000000000001376.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

4. TO J, Muller T, Bozinov O, Regli L, et al
   Intraoperative MRI in pediatric brain tumor surgery: Optimizing surgical decision-making and extent of resection.
   Childs Nerv Syst. 2026;42:367.
   PubMed         Abstract available
   
   

   
   Eur J Cancer

5. BJORKSTROM K, Fager A, Liu C, Ny L, et al
   Flipped versus traditional nivolumab plus ipilimumab dosing in patients with melanoma brain metastases.
   Eur J Cancer. 2026;247:117048.
   PubMed         Abstract available
   
   

   
   J Neurooncol

6. UDOVICICH C, Tseng CL, Detsky J, Chen H, et al
   Reirradiation outcomes following salvage conventionally fractionated Gamma Knife stereotactic radiotherapy (SFGK) to recurrent primary non-glial brain tumors.
   J Neurooncol. 2026;179:88.
   PubMed         Abstract available
   
   
7. ALLMENDINGER FJK, Cherniienko Y, Lischalk J, Walter J, et al
   Efficacy and safety of proton radiotherapy for progressive or surgically unfavorable adult pilocytic astrocytoma: a single-center experience.
   J Neurooncol. 2026;179:89.
   PubMed         Abstract available
   
   
8. GHOCHE MT, Miki K, Yuan F, Mantica M, et al
   Metabolic modulation of glioblastoma by dietary intervention: a systematic review.
   J Neurooncol. 2026;179:90.
   PubMed         Abstract available
   
   
9. XIA Y, Yang L, Davidson A, Khalilullah T, et al
   Characterizing intradural spinal metastasis in the metastatic cascade: clinical course, dissemination timing, and molecular features in 69 patients.
   J Neurooncol. 2026;179:87.
   PubMed         Abstract available
   
   
10. MARGHERITA C, Pietro Z, Andrea B, Leonardo B, et al
    Impact of 5-ALA and sodium fluorescein on FLAIR volume extent of resection and survival in IDH-wildtype glioblastoma.
    J Neurooncol. 2026;179:86.
    PubMed         Abstract available
    
    
11. NOREN H, Pelofsky G, Suffren B, Mittelman L, et al
    Quantitative stability of MGMT promoter methylation in recurrent glioma and implications for temozolomide rechallenge.
    J Neurooncol. 2026;179:85.
    PubMed         Abstract available
    
    
12. TOLBA M, Zhang M, Duh JK, Liverani L, et al
    MRI-based radiomics for prognosis of non-midline, pediatric high-grade gliomas.
    J Neurooncol. 2026;179:84.
    PubMed         Abstract available
    
    
13. SEHRAWAT K, Polley MC, Vogelbaum MA, Gilbert M, et al
    The evolution of RTOG and NRG Oncology CNS tumors clinical trials.
    J Neurooncol. 2026;179:83.
    PubMed         Abstract available
    
    
14. TINI P, Donnini F, Battaglia G, Pastina P, et al
    Brain dose burden is associated with treatment-related lymphopenia in IDH-wildtype glioblastoma: dosimetric determinants and prognostic impact.
    J Neurooncol. 2026;179:81.
    PubMed         Abstract available
    
    
15. DE SOUZA JVG, Pretto KP, da Silva LVG, Oenning BAM, et al
    CD73 and PD-L1 expression in WHO grade 1 and grade 2 meningiomas: an exploratory analysis of purinergic and immune-related profiles.
    J Neurooncol. 2026;179:82.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

16. SOUKUP J, Novakova M, Hojny J, Trnkova M, et al
    Unusual immunohistochemical profiles in hemangioblastomas and their relevance in differential diagnosis: A comprehensive study of 112 cases.
    J Neuropathol Exp Neurol. 2026;85:992-1003.
    PubMed         Abstract available
    
    
17. WANG Y, Belakhoua S, Yang Y, Serrano J, et al
    Histopathological and molecular heterogeneity of dysembryoplastic neuroepithelial tumors.
    J Neuropathol Exp Neurol. 2026;85:1033-1040.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

18. LAYER JP, Schneider M, Holzel M, Herrlinger U, et al
    Beyond Dose Escalation in Glioblastoma: Lessons Learned from INTRAGO-II and the Case for Targeting Tumor Biology.
    Neuro Oncol. 2026 Sep 17:noag166. doi: 10.1093.
    PubMed        
    
    
19. RAMASWAMY V, Tabori U
    BRAF-altered glioma in children and adults: From soup to nuts.
    Neuro Oncol. 2026 Sep 16:noag191. doi: 10.1093.
    PubMed        
    
    
20. WU L, Cheng L, Huang B, Huang R, et al
    The Spatiotemporal Evolution of Radiation Resistance in Glioblastoma.
    Neuro Oncol. 2026 Sep 15:noag209. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

21. PANTOJA-BURBANO OA, Tugores-Garcias M, Richart V, Mejia-Leon AF, et al
    Pituitary neuroendocrine tumors: imaging features, clinical relevance, and a proposal for standardized MRI reporting.
    Neuroradiology. 2026 Aug 8. doi: 10.1007/s00234-026-04116.
    PubMed         Abstract available
    
    
22. EROL S, Baytok A, Ari A, Ozer H, et al
    Core-based voxel-wise T2-FLAIR mismatch analysis for differentiation of IDH-mutant astrocytomas from oligodendrogliomas.
    Neuroradiology. 2026;68:2439-2451.
    PubMed         Abstract available
    
    
23. DUAN C, Zhang J, Bian X, Hu J, et al
    Clinical feasibility of contrast-enhanced 7 T MPRAGE with universal pulses for intracranial tumor imaging: a preliminary study.
    Neuroradiology. 2026 Jun 1. doi: 10.1007/s00234-026-04050.
    PubMed         Abstract available
    
    

    
    Neurosurgery

24. FAILLOT M, Goldwirt L, Jouenne F, Kramkimel N, et al
    Continuous Intrathecal Infusion of Nivolumab in Advanced Melanoma With Concomitant Leptomeningeal Disease: Efficacy, Safety, and Pharmacokinetics.
    Neurosurgery. 2026 Feb 4. doi: 10.1227/neu.0000000000003924.
    PubMed         Abstract available
    
    
25. KITE T, Wegner RE, Karlovits S, Herbst J, et al
    Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma: Results From the International Radiosurgery Research Foundation.
    Neurosurgery. 2026 Jan 14. doi: 10.1227/neu.0000000000003903.
    PubMed         Abstract available
    
    

    
    Oncogene

26. RIVERA-CARABALLO KA, Vazquez-Arreguin K, Singh H, Sahu U, et al
    Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma.
    Oncogene. 2026 Sep 12. doi: 10.1038/s41388-026-03985.
    PubMed         Abstract available
    
    

    
    PLoS One

27. ASSAF S, Heemskerk K, Hao X, Luchman HA, et al
    The COP9 signalosome subunit CSN1 regulates glioblastoma stem cell growth.
    PLoS One. 2026;21:e0358568.
    PubMed         Abstract available
    
    
28. SUN J, Wu M, Li J, Weng J, et al
    Choroid plexus volume variation in patients with gliomas, glioneuronal and neuronal tumors: Associations with tumor characteristics.
    PLoS One. 2026;21:e0357498.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

29. EISEMANN T, Chambers KR, Beigi Masihi M, Tzaridis T, et al
    Local delivery of interferon restores antigen presentation and sensitizes medulloblastoma to T cell killing.
    Proc Natl Acad Sci U S A. 2026;123:e2531269123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum